Porton Fine Chemicals Ltd. (300363) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transcription

1 Porton Fine Chemicals Ltd. (300363) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

2 Porton Fine Chemicals Ltd. (300363) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2

3 Porton Fine Chemicals Ltd. (300363) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Porton Fine Chemicals Ltd. (Porton) is a pharmaceutical service provider that manufactures, research and markets customized chiral intermediates, chiral synthons chemical building blocks. The company offers custom and contract chemical development and manufacturing services to the pharmaceutical industry. It offers a wide range of highly reactive reagents, chiral chromatography products, unnatural amino acids and heterocylic products. Porton also provides regulatory support for the commercialization of active pharmaceutical ingredients and intermediates of APIs. The company has presence in China, Belgium and the US. Porton is headquartered in Yubei, China. Porton Fine Chemicals Ltd. (300363) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. 3

4 - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH447815D Number of Pages : 16 Report Format : PDF Publisher Information : 4

5 5

6 Table Of Contents for Porton Fine Chemicals Ltd. (300363) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deal Details 10Venture Financing 10Porton Fine Chemicals Raises US$10 Million In Venture Financing 10Debt Offering 11Porton Fine Chemicals Plans to Raise up to USD71 Million in Private Placement of Notes 11Acquisition 12Porton Fine Chemicals Plans to Acquire Jiangxi Dongbang Pharma for USD42 Million 12Porton Fine Chemicals Ltd. - Key Competitors 13Key Employees 14Locations And Subsidiaries 15Head Office 15Other Locations & Subsidiaries 15Appendix 16Methodology 16About GlobalData 16Contact Us 16Disclaimer 16 6

7 List Of Tables in Porton Fine Chemicals Ltd. (300363) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Key Facts, Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Porton Fine Chemicals Ltd., Deals By Therapy Area, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD Porton Fine Chemicals Raises US$10 Million In Venture Financing 10 Porton Fine Chemicals Plans to Raise up to USD71 Million in Private Placement of Notes 11 Porton Fine Chemicals Plans to Acquire Jiangxi Dongbang Pharma for USD42 Million 12 Porton Fine Chemicals Ltd., Key Competitors 13 Porton Fine Chemicals Ltd., Key Employees 14 Porton Fine Chemicals Ltd., Subsidiaries 15 7

8 List Of Figures, Charts and Diagrams in Porton Fine Chemicals Ltd. (300363) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Porton Fine Chemicals Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD

9 How to Buy... Porton Fine Chemicals Ltd. (300363) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9